Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
10,356
datasets available to search
ShareScore release 0.9.0
Dataset results
10,356 results for “Severity”
Efficacy and Safety of Delgocitinib Cream in Adults With Moderate to Severe Chronic Hand Eczema
ClinicalTrials.gov study NCT04871711. IPD Sharing: NO. Countries: 6. Publications: 4.
Study to Assess the Short- and Long-term Efficacy of Certolizumab Pegol Plus Methotrexate Compared to Adalimumab Plus Methotrexate in Subjects With Moderate to Severe Rheumatoid Arthritis (RA) Inadequ
ClinicalTrials.gov study NCT01500278. IPD Sharing: Not stated. Countries: 20. Publications: 3.
A Comparative Study Between ABP 501 and Humira® in Participants With Moderate to Severe Plaque Psoriasis
ClinicalTrials.gov study NCT05073315. IPD Sharing: YES. Countries: 6. Publications: 0.
A Study Of Tocilizumab in Patients With Moderate to Severe Active Rheumatoid Arthritis Who Have an Inadequate Response to or Are Unable to Tolerate Biologic and Non-Biologic Disease-modifying Antirheu
ClinicalTrials.gov study NCT00891020. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Efficacy, Safety and Immunogenicity of BI 695501 Versus Humira® in Patients With Moderate to Severe Chronic Plaque Psoriasis
ClinicalTrials.gov study NCT02850965. IPD Sharing: Not stated. Countries: 8. Publications: 3.
Efficacy and Safety Study of Mepolizumab Adjunctive Therapy in Participants With Severe Eosinophilic Asthma on Markers of Asthma Control
ClinicalTrials.gov study NCT02281318. IPD Sharing: YES. Countries: 19. Publications: 7.
A Study of GSK3511294 (Depemokimab) in Participants With Severe Asthma With an Eosinophilic Phenotype
ClinicalTrials.gov study NCT04718103. IPD Sharing: YES. Countries: 11. Publications: 2.
Glycine Supplement for Severe COVID-19
ClinicalTrials.gov study NCT04443673. IPD Sharing: YES. Countries: 1. Publications: 29.
Efficacy and Safety of GSK3196165 Versus Placebo and Tofacitinib in Participants With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Conventional Synthetic (cs)/
ClinicalTrials.gov study NCT03970837. IPD Sharing: YES. Countries: 18. Publications: 1.
Treatment of Severe Coronavirus Disease 2019 (COVID-19) With Convalescent Plasma
ClinicalTrials.gov study NCT04502472. IPD Sharing: NO. Countries: 1. Publications: 15.
Efficacy and Safety Study of Mepolizumab in Subjects With Severe Hypereosinophilic Syndrome (HES)
ClinicalTrials.gov study NCT02836496. IPD Sharing: YES. Countries: 13. Publications: 6.
Phase 3 Safety and Efficacy Study of ART-123 in Subjects With Severe Sepsis and Coagulopathy
ClinicalTrials.gov study NCT01598831. IPD Sharing: Not stated. Countries: 24. Publications: 2.
Safety and Efficacy Trial of RPC1063 for Moderate to Severe Ulcerative Colitis
ClinicalTrials.gov study NCT02435992. IPD Sharing: Not stated. Countries: 30. Publications: 6.
Study of Dupilumab in Adult Patients With Extrinsic Moderate-to-Severe Atopic Dermatitis
ClinicalTrials.gov study NCT01548404. IPD Sharing: Not stated. Countries: 5. Publications: 2.
Study of the Drug Efalizumab (Raptiva), for Adult Patients With Moderate to Severe Plaque Psoriasis
ClinicalTrials.gov study NCT00115076. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Study To Evaluate The Efficacy Of Tofacitinib In Moderate To Severe Alopecia Areata, Totalis And Universalis
ClinicalTrials.gov study NCT02299297. IPD Sharing: YES. Countries: 1. Publications: 1.
Co-crystal E-58425 vs Tramadol and Celecoxib for Moderate to Severe Acute Pain After Bunionectomy. Phase III Clinical Trial.
ClinicalTrials.gov study NCT03108482. IPD Sharing: NO. Countries: 1. Publications: 2.
BAY79-4980 Compared to rFVIII-FS in Previously Treated Patients With Severe Hemophilia A
ClinicalTrials.gov study NCT00623727. IPD Sharing: Not stated. Countries: 26. Publications: 2.
Placebo-controlled Efficacy and Safety Study of GSK3511294 (Depemokimab) in Participants With Severe Asthma With an Eosinophilic Phenotype
ClinicalTrials.gov study NCT04719832. IPD Sharing: YES. Countries: 12. Publications: 2.
Alemtuzumab to Treat Severe Aplastic Anemia
ClinicalTrials.gov study NCT00195624. IPD Sharing: Not stated. Countries: 1. Publications: 7.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.